SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Instruments Regulatory News (OXIG)

Share Price Information for Oxford Instruments (OXIG)

Share Price is delayed by 15 minutes
Get Live Data
2,878.00    130.00 (4.73%)
Bid:
2,846.00
Ask:
2,862.00
Spread: 16.00 (0.562%)
Market Cap: £1.59b
OXIG Live PriceLast checked at - London Stock Exchange

Intraday Oxford Instruments Share Chart

AGM Statement

10 Sep 2013 07:00

RNS Number : 5749N
Oxford Instruments PLC
10 September 2013
 



Oxford Instruments plc

Chairman's AGM Statement 2013

  

Oxford Instruments plc, a leading provider of high technology tools and systems for industry and research, is holding its annual general meeting today in which the Chairman, Nigel Keen will make the following statement:

 

"In June 2011 we outlined our 14 Cubed objective to achieve a compound annual revenue growth rate of 14% and a return on sales of 14% by the financial year ending March 2014. It was anticipated that this objective would be achieved predominantly through organic growth and continuing internal efficiency improvements, augmented by targeted acquisitions.

 

The year to March 2013 was the second year of the 14 Cubed plan and we saw compound revenue growth of 15.6% over the two years with return on sales last year of 14.2%.

 

In the current year, average monthly orders in our Nanotechnology Tools sector are ahead of last year in Asia but are behind in North America and Europe as government agencies in these territories examine their spending on Research and Development. We believe this is particularly true in the USA where the uncertainty caused by budget sequestration has caused orders to be delayed. Asylum Technology, which we acquired in December 2012, is performing well, with results in line with expectations.

 

Our Industrial Products sector has seen growth in average monthly orders over the previous year in Asia and Europe as global economies begin to recover. North America is still down on the prior year but the trend is improving.

 

Our third party service business is performing well with the recently acquired Platinum Medical Imaging business continuing to gain traction and delivering the integration benefits.

  

Outlook

The growth in the order intake rate in Industrial Products and third party Service is encouraging but the slowness in R&D markets in the Western economies means that the year is likely to be more second half weighted than has been seen in recent periods. This will be aided by the continuing recovery in trading conditions in North America

 

 

Enquiries:

 

Oxford Instruments plc Tel: 01865 393200

Jonathan Flint, Chief Executive

Kevin Boyd, Group Finance Director

 

 

MHP Communications Tel: 020 3128 8100

Rachel Hirst / Rory King

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMUKVKROBAKRAR
Date   Source Headline
3rd Aug 202012:07 pmRNSSecond Price Monitoring Extn
3rd Aug 202012:02 pmRNSPrice Monitoring Extension
30th Jul 202012:08 pmRNSSecond Price Monitoring Extn
30th Jul 202012:03 pmRNSPrice Monitoring Extension
24th Jul 202012:07 pmRNSSecond Price Monitoring Extn
24th Jul 202012:02 pmRNSPrice Monitoring Extension
23rd Jul 202012:07 pmRNSSecond Price Monitoring Extn
23rd Jul 202012:02 pmRNSPrice Monitoring Extension
22nd Jul 202012:08 pmRNSSecond Price Monitoring Extn
22nd Jul 202012:02 pmRNSPrice Monitoring Extension
21st Jul 20204:10 pmPRNHolding(s) in Company
16th Jul 202012:07 pmRNSSecond Price Monitoring Extn
16th Jul 202012:02 pmRNSPrice Monitoring Extension
14th Jul 20201:43 pmPRNNotice of AGM
14th Jul 202012:02 pmRNSPrice Monitoring Extension
13th Jul 20201:35 pmPRNDirector/PDMR Shareholding
9th Jul 202010:13 amPRNTotal Voting Rights
6th Jul 202012:02 pmRNSPrice Monitoring Extension
2nd Jul 20203:50 pmPRNBlocklisting - Interim Review
2nd Jul 20209:37 amPRNHolding(s) in Company
25th Jun 20209:55 amPRNHolding(s) in Company
25th Jun 20209:34 amPRNHolding(s) in Company
11th Jun 202012:07 pmPRNDirector/PDMR Shareholding
10th Jun 202012:02 pmRNSPrice Monitoring Extension
9th Jun 20207:00 amRNSAppointment of Independent Non-Executive Director
9th Jun 20207:00 amRNSPreliminary Results
2nd Jun 202010:41 amPRNTotal Voting Rights
18th May 202012:07 pmRNSSecond Price Monitoring Extn
18th May 202012:02 pmRNSPrice Monitoring Extension
12th May 20201:32 pmPRNDirector/PDMR Shareholding
7th May 20205:07 pmPRNTotal Voting Rights
5th May 202012:02 pmRNSPrice Monitoring Extension
4th May 20208:27 amPRNDisclosure of Rights Attached to Equity Shares
1st May 202012:07 pmRNSSecond Price Monitoring Extn
1st May 202012:02 pmRNSPrice Monitoring Extension
30th Apr 202012:07 pmRNSSecond Price Monitoring Extn
30th Apr 202012:02 pmRNSPrice Monitoring Extension
27th Apr 202012:03 pmRNSPrice Monitoring Extension
24th Apr 202012:02 pmRNSPrice Monitoring Extension
21st Apr 202012:02 pmRNSPrice Monitoring Extension
16th Apr 202010:51 amPRNDirector/PDMR Shareholding
3rd Apr 202012:39 pmPRNDirector Declaration
1st Apr 202012:03 pmRNSPrice Monitoring Extension
1st Apr 202010:06 amPRNHolding(s) in Company
30th Mar 20207:00 amRNSSuspension of Interim Dividend
20th Mar 202012:07 pmRNSSecond Price Monitoring Extn
20th Mar 202012:02 pmRNSPrice Monitoring Extension
19th Mar 20204:41 pmRNSSecond Price Monitoring Extn
19th Mar 20204:36 pmRNSPrice Monitoring Extension
18th Mar 20207:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.